High prices not only pose a challenge to patient access, but they also raise a fundamental question: Are we creating these therapies the wrong way?
More than 13% of American adults -- or about 34 million people -- report knowing of at least one friend or family member in the past five years who died after not receiving needed medical treatment because they were unable to pay for it.
Two-year campaign opposing cost-saving plans featured secret payments, a widely criticized consultant's report, and celebrity drug cops.
"The pharmaceutical industry is now the most poorly regarded industry in Americans' eyes, ranking last on a list of 25 industries that Gallup tests annually."
New data show how negotiating for the 250 most-expensive drugs could save patients, taxpayers billions.
If the children for whom these medicines are created continue to suffer and die, it’s as if the drugs were never made at all.
The analysis, using data from CMS’ Medicare Part D Drug Spending Dashboard, shows that less than 1 percent of drugs accounts for 17 percent of spending and 3.5 percent account for nearly 60 percent of spending.